These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38831635)

  • 41. Cellular senescence mediates fibrotic pulmonary disease.
    Schafer MJ; White TA; Iijima K; Haak AJ; Ligresti G; Atkinson EJ; Oberg AL; Birch J; Salmonowicz H; Zhu Y; Mazula DL; Brooks RW; Fuhrmann-Stroissnigg H; Pirtskhalava T; Prakash YS; Tchkonia T; Robbins PD; Aubry MC; Passos JF; Kirkland JL; Tschumperlin DJ; Kita H; LeBrasseur NK
    Nat Commun; 2017 Feb; 8():14532. PubMed ID: 28230051
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human senescent fibroblasts trigger progressive lung fibrosis in mice.
    Hernandez-Gonzalez F; Prats N; Ramponi V; López-Domínguez JA; Meyer K; Aguilera M; Muñoz Martín MI; Martínez D; Agusti A; Faner R; Sellarés J; Pietrocola F; Serrano M
    Aging (Albany NY); 2023 Jul; 15(14):6641-6657. PubMed ID: 37393107
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis.
    Chang CJ; Lin CF; Lee CH; Chuang HC; Shih FC; Wan SW; Tai C; Chen CL
    Biochem Pharmacol; 2021 Jan; 183():114356. PubMed ID: 33285108
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Myofibroblast fate plasticity in tissue repair and fibrosis: Deactivation, apoptosis, senescence and reprogramming.
    Merkt W; Zhou Y; Han H; Lagares D
    Wound Repair Regen; 2021 Jul; 29(4):678-691. PubMed ID: 34117675
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thy-1 interaction with Fas in lipid rafts regulates fibroblast apoptosis and lung injury resolution.
    Liu X; Wong SS; Taype CA; Kim J; Shentu TP; Espinoza CR; Finley JC; Bradley JE; Head BP; Patel HH; Mah EJ; Hagood JS
    Lab Invest; 2017 Mar; 97(3):256-267. PubMed ID: 28165468
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Forefront: MiR-34a-Knockout Mice with Wild Type Hematopoietic Cells, Retain Persistent Fibrosis Following Lung Injury.
    Bulvik R; Biton M; Berkman N; Breuer R; Wallach-Dayan SB
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210149
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Matrix Metalloproteinases Retain Soluble FasL-mediated Resistance to Cell Death in Fibrotic-Lung Myofibroblasts.
    Nareznoi D; Konikov-Rozenman J; Petukhov D; Breuer R; Wallach-Dayan SB
    Cells; 2020 Feb; 9(2):. PubMed ID: 32053892
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
    Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
    Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TNF-α-induced NF-κB activation promotes myofibroblast differentiation of LR-MSCs and exacerbates bleomycin-induced pulmonary fibrosis.
    Hou J; Ma T; Cao H; Chen Y; Wang C; Chen X; Xiang Z; Han X
    J Cell Physiol; 2018 Mar; 233(3):2409-2419. PubMed ID: 28731277
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective Vulnerability of Senescent Glioblastoma Cells to BCL-XL Inhibition.
    Rahman M; Olson I; Mansour M; Carlstrom LP; Sutiwisesak R; Saber R; Rajani K; Warrington AE; Howard A; Schroeder M; Chen S; Decker PA; Sananikone EF; Zhu Y; Tchkonia T; Parney IF; Burma S; Brown D; Rodriguez M; Sarkaria JN; Kirkland JL; Burns TC
    Mol Cancer Res; 2022 Jun; 20(6):938-948. PubMed ID: 35191501
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems.
    Andugulapati SB; Gourishetti K; Tirunavalli SK; Shaikh TB; Sistla R
    Phytomedicine; 2020 Nov; 78():153298. PubMed ID: 32781391
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BH3 mimetics selectively eliminate chemotherapy-induced senescent cells and improve response in TP53 wild-type breast cancer.
    Shahbandi A; Rao SG; Anderson AY; Frey WD; Olayiwola JO; Ungerleider NA; Jackson JG
    Cell Death Differ; 2020 Nov; 27(11):3097-3116. PubMed ID: 32457483
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cell senescence and fibrotic lung diseases.
    Liu RM; Liu G
    Exp Gerontol; 2020 Apr; 132():110836. PubMed ID: 31958492
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Noncanonical Wnt Signaling Promotes Myofibroblast Differentiation in Pulmonary Fibrosis.
    Liu T; Gonzalez De Los Santos F; Hirsch M; Wu Z; Phan SH
    Am J Respir Cell Mol Biol; 2021 Nov; 65(5):489-499. PubMed ID: 34107237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Senotherapy for lung diseases.
    Barnes PJ
    Adv Pharmacol; 2023; 98():249-271. PubMed ID: 37524489
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-β-induced fibroblast to myofibroblast differentiation.
    Liu P; Miao K; Zhang L; Mou Y; Xu Y; Xiong W; Yu J; Wang Y
    Respir Res; 2020 Feb; 21(1):58. PubMed ID: 32075634
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Depletion of SASP senescent cardiomyocytes with senolytic drugs confers therapeutic effects in doxorubicin-related cardiotoxicity.
    Xia W; Chen H; Yang H; Zhu L; Xie C; Hou M
    FEBS J; 2024 Sep; 291(18):4029-4042. PubMed ID: 38857187
    [TBL] [Abstract][Full Text] [Related]  

  • 58. BH3 mimetics as anti-fibrotic therapy: Unleashing the mitochondrial pathway of apoptosis in myofibroblasts.
    Kuehl T; Lagares D
    Matrix Biol; 2018 Aug; 68-69():94-105. PubMed ID: 29408011
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Albendazole ameliorates aerobic glycolysis in myofibroblasts to reverse pulmonary fibrosis.
    Zeng C; Yue H; Wang C; Ju X; Wang T; Fu X; Zhou Q; Zhang H; He L; Yu J; Wang Y
    J Transl Med; 2024 Oct; 22(1):910. PubMed ID: 39375691
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic value of small molecule inhibitor to plasminogen activator inhibitor-1 for lung fibrosis.
    Huang WT; Vayalil PK; Miyata T; Hagood J; Liu RM
    Am J Respir Cell Mol Biol; 2012 Jan; 46(1):87-95. PubMed ID: 21852684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.